Review
doi: 10.1093/schbul/sbs099.
Epub 2012 Sep 10.
Paliperidone palmitate for schizophrenia
Affiliations
- PMID: 22966147
- PMCID: PMC3494051
- DOI: 10.1093/schbul/sbs099
Item in Clipboard
Review
Paliperidone palmitate for schizophrenia
Schizophr Bull.
2012 Nov.
No abstract available
Figures
Leaving the study early for any reason.
Similar articles
-
Paliperidone palmitate for refractory and clozapine-resistant schizophrenia.J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):e14-6. doi: 10.1176/appi.neuropsych.13120374. Epub 2014 Dec 12. J Neuropsychiatry Clin Neurosci. 2015. PMID: 25716490
-
Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia.Rev Recent Clin Trials. 2012 Feb;7(1):2-9. doi: 10.2174/157488712799363307. Rev Recent Clin Trials. 2012. PMID: 22023179 Review.
-
A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia.Neuropsychopharmacology. 2010 Sep;35(10):2072-82. doi: 10.1038/npp.2010.79. Epub 2010 Jun 16. Neuropsychopharmacology. 2010. PMID: 20555312 Free PMC article. Clinical Trial.
-
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial.BMC Psychiatry. 2011 May 10;11:79. doi: 10.1186/1471-244X-11-79. BMC Psychiatry. 2011. PMID: 21569242 Free PMC article. Clinical Trial.
-
Paliperidone palmitate injection: Its efficacy, safety and tolerability in schizophrenia.Drugs Today (Barc). 2010 Jul;46(7):463-71. doi: 10.1358/dot.2010.46.7.1514647. Drugs Today (Barc). 2010. PMID: 20683501 Review.
Cited by
-
Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study.BMC Psychiatry. 2021 Oct 15;21(1):507. doi: 10.1186/s12888-021-03513-7. BMC Psychiatry. 2021. PMID: 34654391 Free PMC article.
-
Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review.Patient Prefer Adherence. 2015 May 25;9:695-706. doi: 10.2147/PPA.S63948. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26082620 Free PMC article. Review.
-
An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs.Neurosci Biobehav Rev. 2023 Dec;155:105454. doi: 10.1016/j.neubiorev.2023.105454. Epub 2023 Nov 2. Neurosci Biobehav Rev. 2023. PMID: 37925094 Free PMC article.
-
Paliperidone Palmitate-induced Urinary Incontinence: A Case Report.Clin Psychopharmacol Neurosci. 2016 Feb 29;14(1):96-100. doi: 10.9758/cpn.2016.14.1.96. Clin Psychopharmacol Neurosci. 2016. PMID: 26792046 Free PMC article.
References
-
- Nussbaum AM, Stroup TS. Paliperidone palmitate for schizophrenia Cochrane Database Syst Rev 2012. s. Art. No.: CD008296. doi:10.1002/14651858.CD008296.pub2 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
